Kratos Introduces OpenSpace™ Wideband Software Receiver for Earth Observation and Remote Sensing Missions
SAN DIEGO, Sept. 03, 2020 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (Nasdaq: KTOS), a leading National Security […]
Passage Bio to Participate in Citi’s 15th Annual BioPharma Virtual Conference
PHILADELPHIA, Sept. 03, 2020 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a genetic medicines company focused on developing transformative […]
NMI Holdings, Inc. Releases Monthly Operating Statistics for August 2020
EMERYVILLE, Calif., Sept. 03, 2020 (GLOBE NEWSWIRE) — NMI Holdings, Inc. (Nasdaq: NMIH) today reported selected operating statistics for the […]
VirTra Receives $863,000 Order from Customs and Border Protection
TEMPE, Ariz., Sept. 03, 2020 (GLOBE NEWSWIRE) — VirTra, Inc. (NASDAQ: VTSI) (“VirTra”), a global provider of training simulators for the […]
CRISPR Therapeutics to Present at the Wells Fargo 2020 Virtual Healthcare Conference
ZUG, Switzerland and CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on […]
Vaxart, Inc. to Participate in September Virtual Investor Conferences
– H.C. Wainwright: 22nd Annual Global Investment Conference – September 14th – 16th– Sachs Associates: 20th Annual Biotech in Europe […]
X4 Pharmaceuticals to Participate in Three September Virtual Investor Conferences
CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development […]
Itamar Medical to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020
CAESAREA, Israel, Sept. 03, 2020 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology and digital […]
Cue Biopharma to Present at Upcoming Investor Conferences in September 2020
CAMBRIDGE, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) — Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel […]
EDAP Announces First Patients Treated in Phase 2 Study of Focal One for the Treatment of Deep Invasive Endometriosis
· First patients already treated as recruitment acceleratesLYON, France, September 3, 2020 — EDAP TMS SA (Nasdaq: EDAP), the […]
